CTKB today
$5.76-$0.03 (-0.52%)close Nov 11, 2026Trend
DailyUptrend (starting)
4 hourBearish
1 hourDescending Triangle
15 minLeaning Bullish
5 minStrong Bearish
Daily trend turns down below $3.31
Key levels
Resistance$6.33
Resistance$5.99
Support$5.30
Support$4.84
Latest news & SEC filings
AnalystStephens & Co. keeps Overweight rating on Cytek Biosciences
AnalystStephens & Co. keeps Overweight rating on Cytek Biosciences, lifts target to $7
ProductCytek's Aurora Evo Platform Wins Drug Discovery Innovation Award
EarningsCytek Biosciences posts Q3 2026 results
All CTKB news →About Cytek Biosciences
Cytek Biosciences makes instruments and related products for analyzing cells in life science research and clinical settings. Its Full Spectrum Profiling technology is used in the Cytek Aurora, Northern Lights, and Aurora CS systems, which examine and sort cells by their fluorescence signatures. The company also sells Amnis imaging flow cytometers, Guava benchtop analyzers, reagents, software, and support services. Its customers include drug developers, universities, research institutes, and contract research organizations around the world.
Based on the company's 10-K filed Feb 26, 2026.
Nasdaq · Technology
Cytek Biosciences, Inc. (CTKB)
What Is the Price Target for CTKB?
SEPT Low Target
$4.75
SEPT Mid Target
$5.12
SEPT High Target
$5.50
Analyst Consensus
$5.12
Is CTKB a Buy or Sell Right Now?
Thesis
- •Revenue growing 0.5% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for CTKB.
Start Free Trial →Is CTKB Overvalued or Undervalued?
Valuation Verdict
FAIR
Methods Used
P/B, Analyst Consensus
Fair Value
$5.64
38
Moat Score
NONE
3/9
Piotroski Score
4.5
Altman Z-Score
What Is Smart Money Doing with CTKB?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Busque Philippe | officer | Sale | 263 | $933.65 | May 18, 2026 |
| Busque Philippe | officer | Sale | 378 | $1K | May 18, 2026 |
| Busque Philippe | officer | Sale | 620 | $2K | May 18, 2026 |
| Busque Philippe | officer | Sale | 1,424 | $5K | May 18, 2026 |
| McCombe William D. | officer | Sale | 2,268 | $8K | May 18, 2026 |
| McCombe William D. | officer | Sale | 3,122 | $11K | May 18, 2026 |
| McCombe William D. | officer | Sale | 3,839 | $14K | May 18, 2026 |
| Yan Ming | director officer | Sale | 1,224 | $4K | May 18, 2026 |
| Yan Ming | director officer | Sale | 919 | $3K | May 18, 2026 |
| Yan Ming | director officer | Sale | 1,025 | $4K | May 18, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →CTKB Growth Story
Revenue YoY
0.5%
3yr Revenue CAGR
308.2%
EPS Growth YoY
-940%
FCF Growth YoY
-140.1%
Revenue Trend
STRONG
Dark Pool Trades for CTKB
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for CTKB, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:00:25 | $5.76 | 7,501 | $$43K | SELL |
| 21:00:25 | $5.76 | 4,665 | $$27K | SELL |
| 19:32:57 | $5.76 | 4,600 | $$27K | BUY |
| 18:46:05 | $5.79 | 1,000 | $$6K | BUY |
| 15:57:59 | $5.90 | 9,900 | $$58K | SELL |
5 dark pool trades shown · $$161K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Cytek Biosciences, Inc. (CTKB) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →CTKB — frequently asked questions
What is CTKB stock price today?
Cytek Biosciences, Inc. (CTKB) is at $5.76, down 0.52% (-$0.03) at the Nov 11, 2026 close.
Why is CTKB stock moving today?
Latest CTKB news — Nov 11, 2026: Stephens & Co. keeps Overweight rating on Cytek Biosciences · Nov 10, 2026: Stephens & Co. keeps Overweight rating on Cytek Biosciences, lifts target to $7
What is the CTKB price target?
The average analyst price target for CTKB is $5.12, ranging from $5 to $6, based on 2 analysts. Latest: Stephens & Co. maintains on May 13, 2026.
What do analysts rate CTKB?
Analyst ratings for CTKB: 0 Buy, 2 Hold, 0 Sell — consensus Hold.
Did CTKB beat earnings?
CTKB last reported on Aug 5, 2026: EPS -$0.05 vs -$0.09 expected — a beat of 46.4%.
Does CTKB pay a dividend?
CTKB does not currently pay a dividend.
What are CTKB support and resistance levels?
Support: $5.30, $4.84, $4.29. Resistance: $5.99, $6.33, $6.78.
What are insiders doing with CTKB?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on CTKB?
Nov 11, 2026: Stephens & Co. keeps Overweight rating on Cytek Biosciences · Nov 10, 2026: Stephens & Co. keeps Overweight rating on Cytek Biosciences, lifts target to $7 · Nov 5, 2026: Cytek's Aurora Evo Platform Wins Drug Discovery Innovation Award